Gemcitabine and oxaliplatinum: an effective regimen in patients with refractory and relapsing Hodgkin lymphoma
Antonio Gutierrez,1,* Jose Rodriguez,1,* Jordi Martinez-Serra,1 Jordi Gines,2 Pilar Paredes,1 Florencia Garcia,3 Javier Vercher,4 Josep Balanzat,4 Raquel del Campo,5 Pilar Galan,6 Miguel Morey,1 Antonia Sampol,1,7 Andres Novo,1 Leyre Bento,1 Lucia García,1 Joan Bargay,5 Joan Besalduch1,7...
Main Authors: | Gutierrez A, Rodriguez J, Martinez-Serra J, Gines J, Paredes P, Garcia F, Vercher J, Balanzat J, del Campo R, Galan P, Morey M, Sampol A, Novo A, Bento L, García L, Bargay J, Besalduch J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-11-01
|
Series: | OncoTargets and Therapy |
Online Access: | http://www.dovepress.com/gemcitabine-and-oxaliplatinum-an-effective-regimen-in-patients-with-re-peer-reviewed-article-OTT |
Similar Items
-
Complete response associated with lenalidomide and celecoxib in a case of primary refractory Hodgkin lymphoma
by: Garcia-Recio M, et al.
Published: (2018-10-01) -
Therapeutic Updates for Relapsed and Refractory Classical Hodgkin Lymphoma
by: Timothy J Voorhees, et al.
Published: (2020-10-01) -
Prognostic Role of the Red Blood Cell Distribution Width (RDW) in Hodgkin Lymphoma
by: Ines Herraez, et al.
Published: (2020-11-01) -
TREATMENT OF RELAPSE AND REFRACTORY HODGKIN LYMPHOMA
by: E. A. Baryakh
Published: (2017-06-01) -
Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma
by: A Boland, et al.
Published: (2009-09-01)